Bone marrow mononuclear cells attenuate fibrosis development after severe acute kidney injury (Q43121574)

14 November 2017

Bone marrow mononuclear cells attenuate fibrosis development after severe acute kidney injury (English)

1 reference

14 November 2017

7

1 reference

14 November 2017

5

Denise Maria Avancini Costa Malheiros

1 reference

14 November 2017

Patricia Semedo

1

1 reference

14 November 2017

Cassiano Donizetti-Oliveira

2

1 reference

14 November 2017

Marina Burgos-Silva

3

1 reference

14 November 2017

Marco Antonio Cenedeze

4

1 reference

14 November 2017

Alvaro Pacheco-Silva

6

1 reference

14 November 2017

22 March 2010

1 reference

14 November 2017

Laboratory Investigation

1 reference

14 November 2017

90

1 reference

14 November 2017

5

1 reference

14 November 2017

685-695

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.45

14 November 2017

0 references

cites work

Long-term outcomes after acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Delta analysis of posttransplantation tubulointerstitial damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Persistent renal and extrarenal immune changes after severe ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Epithelial-mesenchymal transition and its implications for fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

The role of tubular epithelial-mesenchymal transition in progressive kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Is kidney injury a reversible process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Stem cell based therapy for skeletal muscle diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Adult stem cell transplantation in stroke: its limitations and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Stem cells for heart cell therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Renal repair and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Mesenchymal stem cells in acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Long-term outcomes of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Inflammation in acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Acute kidney injury leads to inflammation and functional changes in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Uremic lung: new insights into a forgotten condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Kidney-lung crosstalk in the critically ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Effects of different periods of renal ischemia on liver as a remote organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

The local and systemic inflammatory transcriptome after acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Lymphocytes and ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Immune modulation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Multipotent mesenchymal stromal cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Adult bone marrow-derived stem cells for organ regeneration and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Epithelial-to-mesenchymal transition in early transplant tubulointerstitial damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Early epithelial phenotypic changes predict graft fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Mechanisms of progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Bone morphogenetic protein-7 delays podocyte injury due to high glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Reversal of renal disease: is it enough to inhibit the action of angiotensin II?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

BMP7 signaling in renal development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Downregulation of the expression of bone morphogenetic protein 7 in experimental pyelonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Heme oxygenase-1 protects rat kidney from ureteral obstruction via an antiapoptotic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Renoprotective effects of renin-angiotensin-system inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Acute Kidney Injury: New Concepts, Renal Recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Renal Bone Morphogenetic Protein-7 Protects against Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

Chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Mycophenolate mofetil is associated with altered expression of chronic renal transplant histology

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Bone morphogenetic protein-7 (BMP7) in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Acute renal injury in the interferon-gamma gene knockout mouse: effect on cytokine gene expression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Bone morphogenic protein-7 and the kidney: current concepts and open questions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Osteogenic Protein-1: gene expression and treatment in rat remnant kidney model

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

Setting a trap for tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.45

7 January 2021

10.1038/LABINVEST.2010.45

Identifiers

DOI

1 reference

14 November 2017

1 reference